Juvenile Idiopathic Arthritis (JIA)

Dushnicky MJ, Campbell C, Beattie KA, Berard R, Cellucci T, Chan M, Gerschman T, Johnson N, Lim L, Luca N, Miettunen P, Morishita KA, Proulx-Gauthier JP, Rumsey DG, Schmeling H, Scuccimarri R, Tam H, Guzman J, Batthish M; CAPRI Registry Investigators. Impact of the COVID-19 Pandemic on Juvenile Idiopathic Arthritis Presentation and Research Recruitment: Results from the CAPRI Registry (135/140). Rheumatology (Oxford). 2021 Oct 29: keab812. doi: 10.1093/rheumatology/keab812. Online ahead of print.

Oen K, Tian J, Loughin T, Berard R, Chan M, Duffy C, Feldman B, Huber A, Levy D, Rumsey D, Shiff N, Tse S, Tucker L, Watanabe-Duffy K, Guzman J. Causal Pathways to Health-Related Quality of Life in Children with Juvenile Idiopathic Arthritis: Results from the ReACCh-Out Cohort. Accepted Rheumatology (Oxford) 2021. 

Chédeville G, McGuire K, Cabral DA, Shiff NJ, Rumsey DG, Proulx-Gauthier JP, Schmeling H, Berard RA, Batthish M, Soon G, Gerhold K, Gerschman T, Bruns A, Duffy CM, Tucker LB, Guzman J, on behalf of CAPRI Registry Investigators. Parent-Reported Medication Side-Effects and Their Impact on Health-Related Quality of Life in Children with Juvenile Idiopathic Arthritis. Accepted, Arthritis Care & Research 2021. 

Chhabra A, Robinson C, Houghton K, Cabral DA, Morishita K, Tucker LB, Petty RE, Larché M, Batthish M, Guzman J. Rheumatology (Oxford). Long-term outcomes and disease course of children with juvenile idiopathic arthritis in the ReACCh-Out cohort: a two-centre experience. 2020 May 13:keaa118. doi: 10.1093/rheumatology/keaa118. Online ahead of print.

Michelle Batthish, Roberta Berard, David Cabral, Roxana Bolaria, Gaëlle Chédeville, Ciaran Duffy, Kerstin Gerhold, Tommy Gerschman, Adam Huber, Jean-Philippe Proulx-Gauthier, Alan Rosenberg, Dax Rumsey, Heinrike Schmeling, Natalie Shiff, Gordon Soon, Alessandra Bruns, Lori Tucker, Jaime Guzman, for The Canadian Alliance of Pediatric Rheumatology Investigators. A new Canadian inception cohort for juvenile idiopathic arthritis: The Canadian Alliance of Pediatric Rheumatology Investigators Registry. Rheumatology, Volume 59, Issue 10, October 2020, Pages 2796–2805, https://doi.org/10.1093/rheumatology/keaa006

Wright J, Curran J, Rose-Davis B, Cellucci T, Duffy CM, Tucker LB, Batthish M, Huber AM, Lang B, Levy DM, Rumsey DG, Watanabe Duffy KN, Stringer E. Parental Perspectives about Research and Knowledge Translation in Juvenile Idiopathic Arthritis. ACR Open Rheumatol. 2020 Mar;2(3):138-146. doi: 10.1002/acr2.11111. Epub 2020 Jan 29.

Rezaei E, Hogan D, Trost B, Kusalik AJ, Boire G, Cabral DA, Campillo S, Chédeville G, Chetaille AL, Dancey P, Duffy C, Duffy KW, Eng SWM, Gordon J, Guzman J, Houghton K, Huber AM, Jurencak R, Lang B, Laxer RM, Morishita K, Oen KG, Petty RE, Ramsey SE, Scherer SW, Scuccimarri R, Spiegel L, Stringer E, Taylor-Gjevre RM, Tse SML, Tucker LB, Turvey SE, Tupper S, Wintle RF, Yeung RSM, Rosenberg AM; BBOP Study Group. Associations of clinical and inflammatory biomarker clusters with juvenile idiopathic arthritis categories. Rheumatology (Oxford). 2020 May 1;59(5):1066-1075. doi: 10.1093/rheumatology/kez382.

Lalloo C, Harris LR, Hundert AS, Berard R, Cafazzo J, Connelly M, Feldman BM, Houghton K, Huber A, Laxer RM, Luca N, Schmeling H, Spiegel L, Tucker LB, Pham Q, Davies-Chalmers CC, Stinson JN. The iCanCope pain self-management application for adolescents with juvenile idiopathic arthritis: a pilot randomized controlled trial. Rheumatology (Oxford). 2020 Jul 2:keaa178. doi: 10.1093/rheumatology/keaa178. Online ahead of print.

Rezaei E, Hogan D, Trost B, Kusalik AJ, Boire G, Cabral DA, Campillo S, Chédeville G, Chetaille AL, Dancey P, Duffy C, Watanabe Duffy K, Gordon J, Guzman J, Houghton K, Huber AM, Jurencak R, Lang B, Morishita K, Oen KG, Petty RE, Ramsey SE, Scuccimarri R, Spiegel L, Stringer E, Taylor-Gjevre RM, Tse SML, Tucker LB, Turvey SE, Tupper S, Yeung RSM, Benseler S, Ellsworth J, Guillet C, Karananayake C, Muhajarine N, Roth J, Schneider R, Rosenberg AM. Clinical and associated inflammatory biomarker features predictive of short-term outcomes in non-systemic juvenile idiopathic arthritis. Rheumatology (Oxford). 2020 Sep 1;59(9):2402-2411. doi: 10.1093/rheumatology/kez615.

Stinson JN, Lalloo C, Hundert AS, Campillo S, Cellucci T, Dancey P, Duffy C, Ellsworth J, Feldman BM, Huber AM, Johnson N, Jong G, Oen K, Rosenberg AM, Shiff NJ, Spiegel L, Tse SM, Tucker L, Victor JC. Teens Taking Charge: Randomized controlled trial of a web-based self-management program with telephone support for adolescents with juvenile idiopathic arthritis. 2020. J Medical Internet Research. doi: 10.2196/16234.

Henrey A, Rypdal V, Rypdal M, Loughin T, Nordal E, Guzman J; ReACCh-Out and NoSPeR Investigators. Validation of prediction models of severe disease course and nonachievement of remission in juvenile idiopathic arthritis part 2: results of the Nordic model in the Canadian cohort. Arthritis Res Ther. 2020 Jan 15;22(1):10. doi: 10.1186/s13075-019-2091-8.

Barber CEH, Twilt M, Pham T, Currie GR, Benseler S, Yeung RSM, Batthish M, Blanchette N, Guzman J, Lang B, LeBlanc C, Levy DM, O'Brien C, Schmeling H, Soon G, Spiegel L, Whitney K, Marshall DA. A Canadian evaluation framework for quality improvement in childhood arthritis: key performance indicators of the process of care. Arthritis Res Ther. 2020 Mar 19;22(1):53.

Brunner HI, Ruperto N, Zuber Z, Cuttica R, Keltsev V, Xavier RM, Burgos‐Vargas R, Calvo Penades I, Silverman ED, Espada G, Ferrandiz Zavaler M. Efficacy and Safety of Tocilizumab for Polyarticular‐
Course Juvenile Idiopathic Arthritis in the Open‐Label 2‐Year Extension of a Phase 3 Trial
. Arthritis & Rheumatology. 2020 Sep 20. (Kristin Houghton, Pediatric Rheumatology Collaborative Study Group (PRCSG) collaborator)

Quartier P, Alexeeva E, Tamàs C, Chasnyk V, Wulffraat N, Palmblad K, Wouters C, Brunner H, Marzan K, Schneider R, Horneff G. Tapering Canakinumab Monotherapy in Patients with Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results from an Open‐label, Randomized Phase IIIb/IV Study. Arthritis & Rheumatology. 2020 Aug 11. (Kristin Houghton, Pediatric Rheumatology International Trials Organization (PRINTO) collaborator, site investigator)

Vasculitis

Mendel A, Ennis D, Go E, Bakowsky V, Baldwin C, Benseler SM, Cabral DA, Carette S, Clements-Baker M, Clifford AH, Cohen Tervaert JW, Cox G, Dehghan N, Dipchand C, Dhindsa N, Famorca L, Fifi-Mah A, Garner S, Girard LP, Lessard C, Liang P, Noone D, Makhzoum JP, Milman N, Pineau CA, Reich HN, Rhéaume M, Robinson DB, Rumsey DG, Towheed TE, Trudeau J, Twilt M, Yacyshyn E, Yeung RSM, Barra LB, Khalidi N, Pagnoux C. CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update. J Rheumatol. 2021 Apr;48(4):555-566. doi: 10.3899/jrheum.200721. Epub 2020 Sep 15.

Gibson KM, Kain R, Luqmani R, Ross CJ, Cabral DA, and Brown KL (2021). Autoantibodies against lysosome associated membrane protein-2 (LAMP-2) in pediatric chronic systemic vasculitis. Frontiers in Immunology 11: 624758 

Gill EE, Smith M, Gibson KM, Morishita K, Lee AHY, Falsafi R, Graham J, Foell D, Benseler S, Luqmani R, Ross C, PedVas Initiative Investigators, Cabral DA, Hancock REW and Brown KL (2021). Different disease endotypes in phenotypically similar vasculitides affecting small-to-medium sized blood vessels. Frontiers in Immunology. Submitted Dec 2020

Chen A, Mammen C, Guzman J, Al-Abadi E, Benseler SM, Berard RA, Gerstbacher D, Kim S, KleinGitelman M, Chahan PP, James KE, Martin N, McErlane F, Nielsen S, Raghuram J, Shenoi S, Sivaraman V, Tanner T, Yeung RSM, Cabral DA, Morishita KA for ARChiVe Investigators Network within the PedVas Intiative. Variations in glucocorticoid dosing in pediatric antineutrophil cytoplasmic antibody-associated vasculitis with renal disease – a PedVas study. Arthritis Care & Research. Submitted Dec 2020. 

Bowers SM, Gibson KM, Cabral DA, Brown KL (2020). Adenosine Deaminase 2 activity negatively 
correlates with age during childhood
. Pediatric Rheumatology. 18: 54.

Arielle Mendel, .. David A. Cabral, .. Pagnoux, Christian. CanVasc consensus recommendations for the management of antineutrophil cytoplasm antibody-associated vasculitis: 2020 update. The Journal of Rheumatology Sep 2020, jrheum.200721; DOI: 10.3899/jrheum.200721 

Morishita, Kimberly A., Goldman, Ran D. Current Approach to the Evaluation and Management of Incomplete Kawasaki Disease in the Emergency Department. Pediatric Emergency Care: November 
2020 - Volume 36 - Issue 11 - p 537-541 doi: 10.1097/PEC.0000000000002259

Autoinflammatory Diseases 

Tucker LB, Niemietz I, Mangat P, Tekano J, Cabral DA, Morishita KA, Guzman J, Human A, Houghton K, Chan M, Petty RE, Sundqvist M, Brown KL (2021). Children with systemic autoinflammatory diseases have multiple, mixed ethnicities that reflect regional ethnic diversity. Rheumatology. Submitted Jan 2021.

Amarilyo G, Rothman D, Manthiram K et al. (2020). Consensus treatment plans for periodic fever, 
aphthous stomatitis, pharyngitis and adenitis syndrome (PFAPA): a framework to evaluate treatment responses from the childhood arthritis and rheumatology research alliance (CARRA) PFAPA work group
. Pediatric Rheumatology. 18: 31

Other

H Tam, T El Tal, E Go, RSM Yeung. Pediatric inflammatory multisystem syndrome temporally associated with COVID-19: a spectrum of diseases with many names. CMAJ. 2020. doi:10.1503/cmaj.201600.

H Tam, and R Laxer. Secondary hypertrophic osteoarthropathy in pediatric Hodgkin Lymphoma. Arthritis Rheumatol. 2020. doi:10.1002/art.41445.

M Putman, YPE Chock, H Tam, AH Kim, SE Sattui, F Berenbaum, MI Danila, P Korsten, C Sanchez‐Alvarez, JA Sparks, LC Coates, C Palmerlee, A Peirce, A Jayatilleke, SR Johnson, A Kilian, J Liew, LJ Prokop, MH Murad, R Grainger, ZS Wallace, A Duarte‐García. Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐analysis. Arthritis Rheumatol. 2020. doi:10.1002/art.41469.0

Niemietz I, Moraes A, Sundqvist and Brown KL (2020). Hyaluronan primes the oxidative burst in 
human neutrophils
. Journal of Leukocyte Biology 108: 705-713.

Sundqvist M, Niemietz I, Bowers SM, Gibson KM, Brown KL (2020). Anti Neutrophil cytoplasmic antibodies (ANCA): Antigen interactions and downstream effects. Journal of Leukocyte Biology 108: 617-626.

Sabbagh SE, Neely J, Chow A, DeGuzman M, Lai J, Lvovich S, McGrath T, Pereira M, Pinal-Fernandez I, Roberts J, Rouster-Steves K, Schmeling H, Sura A, Tarshish G, Tucker L, Rider LG, Kim S, CARRA JDM Workgroup. Risk factors associated with Pneumocystis jirovecii pneumonia in juvenile myositis in North America. 2020. Rheumatology. doi:10.1093/rheumatology/keaa436

Ma J, Siminoski K, Wang P, Alos N, Cummings EA, Feber J, Halton J, Ho J, Houghton K, Lang B, Miettunen PM. The Accuracy of Prevalent Vertebral Fracture Detection in Children Using Targeted Case‐Finding Approaches. Journal of Bone and Mineral Research. 2020 Mar;35(3):460-8